Specification List Infectious Serology - labor-stoecker.de · Brucella abortus IgA sample type:...

Specification List Infectious Serology

Version: 25/Jul/2019

Dokumenten-Name.: Allgemeine Hinweise zum Leistungsverzeichnis des Klinisch-immunologischen Labors (SV_1092_V_DEUK_A01) Seite 1 von 1 Dokumenten-Nr.: 40000000-0080 Versions-Nr.: Rev 04

Allgemeine Hinweise Dieses Leistungsverzeichnis enthält alle vom Klinisch-immunologischen Labor angebotenen Untersuchungen mit Angaben über die Methoden, die Probenarten und –volumina, die Häufigkeit der Untersuchung, Normwerte und ggf. präanalytische Besonderheiten. Das aktuelle Leistungsverzeichnis kann auf unserer Homepage unter www.labor-stoecker.de heruntergeladen werden.

Bearbeitungsdauer:

Die Proben werden am Tag des Eingangs im Laboratorium registriert und die Untersuchungen wenn möglich am gleichen Tag durchgeführt oder begonnen, so dass der Befundbericht in der Regel spätestens am Tag nach dem Probeneingang an den Empfänger übermittelt werden kann. Wenn Untersuchungen nicht täglich durchgeführt werden sowie durch eventuell notwendige Wiederhol- und/oder Verdünnungsanalysen kann sich die Bearbeitungszeit in Einzelfällen verlängern.

Referenzbereiche:

Die im Leistungsverzeichnis enthaltenen Normwerte entsprechen den Herstellerempfehlungen der verwendeten Testsysteme und dem aktuellen Stand der Wissenschaft und Technik. Durch neue wissenschaftliche Erkenntnisse und technische Fortschritte in der Analysentechnik können sich diese Referenzbereiche ändern. Ausschlaggebend für die Befundinterpretation sind die im Befundbericht angeführten Referenzbereiche und sonstigen Hinweise.

Messunsicherheit:

Das Klinisch-immunologische Labor führt regelmäßige Kontrollen durch und ergreift kontinuierlich Maßnahmen, um Schwankungen und verfahrensbedingte Abweichungen der Messergebnisse zu minimieren. Aufgrund der vorhandenen Messunsicherheit sind grenzwertige und schwach positive Ergebnisse bzw. Ergebnisse, die in der Nähe der Normwerte oder sonstiger medizinischer Entscheidungsgrenzen liegen, vorsichtig zu interpretieren. Auf Anfrage kann für jede quantitative Untersuchung die individuelle Messunsicherheit zur Verfügung gestellt werden. Die meisten der vom Klinisch-immunologischen Labor durchgeführten Untersuchungen (Antikörperdiagnostik) sind jedoch als qualitativ einzustufen.

Vergleichbarkeit von Untersuchungsergebnissen:

Die Ergebnisse verschiedener Testmethoden (z.B. Immunfluoreszenz, ELISA, Blot-Techniken) zum Nachweis der gleichen Antikörper in einer Probe können unterschiedlich ausfallen. Ursache hierfür können unterschiedliche Antigene sein oder die unterschiedliche Immobilisierung des gleichen Antigens auf den verschiedenen Trägermaterialien, die durch Konformationsänderungen des Antigens oder durch sterische Inhibierung die Bindung der Antikörper an das Antigen beeinflussen.

General Information The specifications list contains the range of analysis provided by the clinical immunological laboratory and informs you about the methods, sample types and volumes used, the frequency of analysis, standard values and, if necessary, preanalytical aspects. The specifications list is available on the internet at www.labor-stoecker.de.

Duration:

The samples are registered upon receipt in the laboratory. Preferably, analysis is performed or started on the same day to ensure that the report can be send to the customer generally one day after receipt of the sample at the latest. The time period may be longer in individual cases if the analysis is not carried out daily or retesting of the sample or performing of a dilution series is required.

Reference range:

The standard values given in the specifications list are in accordance with the manufacturer’s recommendations for the test system used and with current scientific and technological knowledge. However, reference ranges may change due to new scientific findings and technical developments in analytical techniques. Interpretation of results is always based on the reference ranges and additional remarks which are given on the report.

Measurement deviations:

The clinical immunological laboratory performs regular checks and maintenance to minimise variations and method-related deviations in the measurement results. Due to existing measurement deviations, borderline and weak-positive results or results that lie near to the normal value or other medical decision limits should be interpreted with care. Information about measurement deviations in individual quantitative analyses can be provided upon request. However, most analyses that are performed by the clinical immunological laboratory (antibody diagnostics) are considered qualitative.

Comparability of test results:

Results from different methods (e.g. immunofluorescence, ELISA, blot techniques) for detecting the same antibodies in a sample may difffer. This can be due to the use of different antigens or to varying immobilisation of the same antigen to different carrier materials, which can influence the binding of the antibody to the antigen through conformational changes in the antigen or through steric inhibition.

Antibodies against

Adenovirus IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Adenovirus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Adenovirus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bartonella henselae IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bartonella henselae IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Infectious serology specification list

Antibodies against

Bartonella quintana IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bartonella quintana IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bordetella parapertussis IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Bordetella parapertussis IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bordetella parapertussis IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Bordetella pertussis IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bordetella pertussis IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bordetella pertussis IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Bordetella-FHA IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

Bordetella-FHA IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 05/14


Antibodies against

Bordetella-pertussis-Toxin IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Bordetella-pertussis-Toxin IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia afzelii IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia afzelii IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia burgdorferi (USA) IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Borrelia burgdorferi (USA) IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia garinii IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia garinii IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18


Antibodies against

Borrelia CSF/serum quotient IgMsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

Borrelia plus VlsE IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Borrelia-RN-AT IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Borrelia-RN-AT IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Brucella abortus IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Brucella abortus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Brucella abortus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Campylobacter coli IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Campylobacter coli IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Campylobacter jejuni IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Antibodies against

Campylobacter jejuni IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/14

Candida albicans IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Candida albicans IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Candida albicans IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Candida crusei IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Antibodies against

Candida glabrata IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Candida parapsilosis IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Candida tropicalis IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Chikungunya Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: biweeklynorm value: see result reportas at: 02/18

Chikungunya Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: biweeklynorm value: see result reportas at: 04/17


Antibodies against

Chlamydia pneumoniae IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Chlamydia pneumoniae IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Chlamydia pneumoniae IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Chlamydia psittaci IgA MIFsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: MIFfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Chlamydia psittaci IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: MIFfrequency: daily (mo-fri)norm value: see result reportas at: 05/15


Antibodies against

Chlamydia psittaci IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: MIFfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Chlamydia trachomatis IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Chlamydia trachomatis IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Chlamydia trachomatis IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Chlamydia trachomatis IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Chlamydia trachomatis IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, MIFfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

CMV IgG aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

CMV IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

CMV IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

CMV CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18


Antibodies against

Coxsackie A IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Coxsackie A IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Coxsackie A IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Coxsackie B IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Coxsackie B IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Coxsackie B IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

CXCL13sample type: CSFsample volume: 1,5 mlmethod: ELISAfrequency: weeklynorm value: see result reportas at: 01/19

Dengue Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: biweeklynorm value: see result reportas at: 04/17

Dengue Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: biweeklynorm value: see result reportas at: 04/17

Dengue Virus NS1 ELISAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportas at: 04/17

Diphtherie Toxoid IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

EBNA IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

EBV IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

EBV IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

EBV-CA IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

EBV-CA IgG Aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

EBV-CA IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

EBV-CA IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

EBV-EA IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 03/15

EBV-EA IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 03/15

EBV-EA IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

EBV-Profile 2 EUROLINE IgG (VCA gp125, VCA p19, EBNA-1, p22, EA-D)sample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

EBV-Profile 2 EUROLINE IgM (VCA gp125, VCA p19, EBNA-1, p22, EA-D)sample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Echinococcus granulosus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISA, EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 12/16

Echinococcus granulosus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 07/14

Echo Virus IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Echo Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Echo Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

TBE Virus IgG ELISA aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/14

TBE Virus CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

TBE virus CSF/serum quotient IgMsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18


Antibodies against

TBE Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

TBE Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Yellow fever virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Yellow fever virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Haemophilus influenzae IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Antibodies against

Haemophilus influenzae IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Hanta-Profile-GLOBAL IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: biweeklynorm value: see result reportas at: 01/19

Hanta-Profile-GLOBAL IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: biweeklynorm value: see result reportas at: 01/19

Hanta Virus Pool 1 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportas at: 01/19

Hanta Virus Pool 1 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportas at: 01/19


Antibodies against

Helicobacter pylori (CagA) IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Helicobacter pylori (CagA) IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Helicobacter pylori IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Helicobacter pylori IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Hepatitis E IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 08/14


Antibodies against

Hepatitis E IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/14

Hepatitis E IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Hepatitis-E IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

HHV-6 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HHV-6 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

HSV 1/2 Pool IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV 1/2 Pool IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV 1/2 Pool IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV 1/2 Pool CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

HSV C1, G1+G2 IgG EUROLINE/WBsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 07/16


Antibodies against

HSV C1, G1+G2 IgM EUROLINE/WBsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINE/Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

HSV-1 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV-1 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV-2 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

HSV-2 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Influenza A Virus IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Influenza A Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Influenza A Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Influenza B Virus IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Influenza B Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Influenza B Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Japanese encephalitis virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweekly (Mo, Do)norm value: see result reportas at: 07/16

Japanese encephalitis virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweekly (Mo, Do)norm value: see result reportas at: 07/16

Klebsiella pneumoniae IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Klebsiella pneumoniae IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Antibodies against

Leg. non-pneumophila IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Legionella pneumophila IgAGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Legionella pneumophila IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Legionella pneumophila ST1-7 IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

Legionella pneumophila ST1-7 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/16


Antibodies against

Legionella pneumophila ST1-7 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/16

Leishmania donovani IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Leishmania donovani IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Leishmania donovani IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Listeria monocytogenes 1/2a IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19


Antibodies against

Listeria monocytogenes 1/2a IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Listeria monocytogenes 1/2a IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 03/14

Listeria monocytogenes 4b IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Listeria monocytogenes 4b IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Listeria monocytogenes 4b IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/14


Antibodies against

Measles Virus IgG aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Measles Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Measles Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Measles Virus CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Mumps Virus CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18


Antibodies against

Mumps Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Mumps Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 07/14

Mycoplasma hominis IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 07/14

Mycoplasma hominis IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Mycoplasma hominis IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Mycoplasma pneumoniae IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Mycoplasma pneumoniae IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Mycoplasma pneumoniae IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Parainfluenza Virus type 1 IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Parainfluenza Virus type 1 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Parainfluenza Virus type 1 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Parainfluenza Virus type 1-4 Pool IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Parainfluenza Virus type 1-4 Pool IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Parainfluenza Virus type 1-4 Pool IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11



Antibodies against







Antibodies against




Parvovirus B19 IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/14

Parvovirus B19 IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/14


Antibodies against

Plasmodium IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportas at: 01/16

RSV IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

RSV IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

RSV IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Rubella Virus IgG aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19


Antibodies against

Rubella Virus IFA aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Rubella Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Rubella Virus CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

Sandfly Fever Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Sandfly Fever Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Antibodies against

Schistosoma mansoni IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFA, ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 05/19

Schistosoma mansoni IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Tetanus-Toxoid IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

TO.R.C.H. Profile IgG EUROLINE (CMV, HSV-1, HSV-2, Rubella, Toxoplasma gondii)sample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

TO.R.C.H. Profile IgM EUROLINE (CMV, HSV-1, HSV-2, Rubella, Toxoplasma gondii)sample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 05/11


Antibodies against

Toxoplasma gondii IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 01/19

Toxoplasma gondii IgG aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Toxoplasma gondii IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 05/15

Toxoplasma gondii IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Toxoplasma gondii CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18


Antibodies against

Treponema pallidum IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 06/19

Treponema pallidum IgGMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Treponema pallidum IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, EUROLINEfrequency: daily (mo-fri)norm value: see result reportas at: 06/19

Treponema pallidum CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

Ureaplasma urealyticum IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Ureaplasma urealyticum IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Usutu Virus IgGsample type: serumsample type 2: plasmasample volume: 1,0 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

VZV IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

VZV IgG aviditysample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

VZV IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

VZV IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFAfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

VZV CSF/serum quotient IgGsample type: serum, plasmasample type 2: CSFsample volume: 1,5 mlmethod: ELISAfrequency: daily (mo-fri)norm value: see result reportas at: 02/18

West Nile Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportas at: 04/17

West Nile Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportas at: 04/17

Yersinia enterocolitica IgAsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11


Antibodies against

Yersinia enterocolitica IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISA, IFA, Westernblotfrequency: daily (mo-fri)norm value: see result reportas at: 02/11

Zika Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportas at: 01/19

Zika Virus IgGsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Zika Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: ELISAfrequency: biweeklynorm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19

Zika Virus IgMsample type: serumsample type 2: plasmasample volume: 1,5 mlmethod: IFAfrequency: biweeklynorm value: see result reportremark: This analysis is not yet fully validated and not covered by the current accreditation scope.as at: 01/19


Specification List Infectious Serology - labor-stoecker.de · Brucella abortus IgA sample type:...

Documents

Transcript of Specification List Infectious Serology - labor-stoecker.de · Brucella abortus IgA sample type:...